Clinical Trials Logo

Filter by:
NCT ID: NCT05348928 Completed - Clinical trials for Continuous Glucose Monitoring

A Pilot Study of the Feasibility and Accuracy of the TrueVie CGM System - A Non-Significant Risk Study

Start date: May 4, 2022
Phase:
Study type: Observational

The purpose of the investigation is to obtain sufficient preliminary information about the performance of the TrueVie Continuous Glucose Monitoring (CGM) device to identify any need for any design modifications.

NCT ID: NCT05348603 Completed - Clinical trials for Patient Participation

Electronic Health Record Strategies to Promote Diverse Participation in Research

Start date: September 13, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effectiveness of enhanced features in an online patient portal including banners, a chatbot, and direct to patient message and traditional mailed letters on increasing interest in research among online patient portal users.

NCT ID: NCT05348200 Completed - Hemorrhoids Clinical Trials

Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids

Start date: April 22, 2022
Phase: Phase 2
Study type: Interventional

A Randomized Phase 2 double blind study which aims to determine the safety and efficacy of CITI-002 cream in adult patients with Goligher's grade II or III hemorrhoids.

NCT ID: NCT05348044 Completed - Stroke Clinical Trials

Enhancing Resilience in Young Stroke Survivors With Res-ET

Start date: May 5, 2022
Phase: N/A
Study type: Interventional

The proposed pilot study will explore the feasibility and preliminary impacts of a 6-week at-home group delivered inspiratory muscle strength training (IMST) exercise intervention on resilience in young stroke survivors. Resilience Exercise Training (Res-ET) intervention on young stroke survivors will assess feasibility of Res-ET and preliminary changes in resilience on young stroke survivors using a quasi-experimental one-group pretest-posttest design within the RE-AIM framework. The connection between resilience and exercise has not been clearly identified in literature, and there is no literature supporting IMST on resilience in young stroke survivors. The Res-ET intervention in young stroke survivors may serve as a pragmatic and novel approach to increase resilience while also increasing physiological and psychosocial well-being of young stroke survivors. Aim 1. Test the feasibility (recruitment, retention, participation, and acceptability) of Res-ET intervention in a sample of young stroke survivors having had a stroke between the age of 18 - 50, AND who experienced a stroke within the last 6 months to 55 years of age AND have been cleared by a physician to participate in IMST exercise. Aim 2. Assess the efficacy potential of Res-ET intervention on resilience, and preliminary direction and magnitude of psychosocial and physiological outcomes in young stroke survivors pre/post Res-ET intervention. Psychosocial outcome measures consist of; positive affect, self-efficacy, meaning/purpose, physical function, fatigue, and social satisfaction. Physiological outcome measures consist of, pulmonary function, physical activity, biometrics, and daily movement. Aim 3. Collect qualitative data to assess acceptability and usability of Res-ET. Data will be collected through interviews and questionnaires about Res-ET feasibility, perceived utility, and satisfaction of the intervention. Perceived changes to resilience, functional capacity/movement (ADL's), and well-being will be recorded, transcribed, and thematically coded

NCT ID: NCT05347979 Completed - Neoplasms Clinical Trials

Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants

Start date: May 25, 2022
Phase: Phase 1
Study type: Interventional

The primary objective is to determine the effect of relacorilant on the pharmacokinetics (PK) of the sensitive P-glycoprotein (P-gp) substrate dabigatran etexilate.

NCT ID: NCT05347602 Completed - Clinical trials for Rheumatoid Arthritis

Gold Factor on Knee Joint Health and Function

Start date: August 3, 2020
Phase: N/A
Study type: Interventional

The purpose of this clinical study was to determine whether gold nanoparticles (AuNP) supplement holds clinical value in improving joint health, function, and quality of life for arthritis patients.

NCT ID: NCT05347485 Completed - Multiple Myeloma Clinical Trials

A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myeloma

Start date: May 13, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of cilta-cel out-of-specification (OOS).

NCT ID: NCT05347290 Completed - Radiation Exposure Clinical Trials

Comparison Of Effective Radiation Shielding Between Rampart IC, M1128 Shield vs Conventional Apron And Shields In Clinical Interventional Procedures

RAMPART
Start date: March 9, 2022
Phase: N/A
Study type: Interventional

Previous studies have documented that orthopedic injuries and musculoskeletal pain are a likely result of wearing heavy leaded aprons. This single-center, randomized 1-3 month clinical study compares conventional lead aprons and ancillary shields to the Rampart IC, M1128 radiation protection system in order to improve radiation safety with minimal orthopedic strain by using the RAMPART device. There will be three study arms, each arm requiring 21 procedures for a total of 63 total procedures, Each procedure will be randomized, instead of individual subjects. Each enrolled subject may be involved in more than one procedure/case. Randomization stratification will be 1:1:1 to either Rampart shield only, lead apron and ancillary shield, or lead apron and Rampart Shield. Real-time dosimeters will be used in each procedure to measure radiation attenuation.

NCT ID: NCT05346991 Completed - Clinical trials for Tobacco Use Cessation

Disseminating an Evidence-based Tobacco Control Intervention for School Teachers in India

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Disseminating an evidence-based tobacco control intervention for School Teachers

NCT ID: NCT05346640 Completed - Foot Drop Clinical Trials

Augmenting Gait in a Population Exhibiting Foot Drop With Adaptive Functional Electrical Stimulation

Start date: June 8, 2021
Phase: N/A
Study type: Interventional

The objective of this study is to investigate the effects of personalized, adaptive, current-steering functional electrical stimulation (FES) of the lower leg to improve gait in people with foot drop.